Al-Samkari H, van Beers EJ, D Morton H, Eber SW, Chonat S, Kuo KHM, Kollmar N, Wang H, Breakey VR, Sheth S et al..  2022.  Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.. Blood Adv. 6(6):1844-1853.

Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..  2022.  The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.

Stacy S, Sheth S, Coleman B, Cerenzia W.  2021.  An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.. Ann Hematol. 100(1):27-35.

Boscoe AN, Yan Y, Hedgeman E, van Beers EJ, Al-Samkari H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S et al..  2021.  Comorbidities and complications in adults with pyruvate kinase deficiency.. Eur J Haematol. 106(4):484-492.

Frangoul H, Altshuler D, M Cappellini D, Chen Y-S, Domm J, Eustace BK, Foell J, de la Fuente J, Grupp S, Handgretinger R et al..  2021.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.. N Engl J Med. 384(3):252-260.

Mensah C, Sheth S.  2021.  Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.. Hematology Am Soc Hematol Educ Program. 2021(1):607-613.

Chonat S, Eber SW, Holzhauer S, Kollmar N, D Morton H, Glader B, Neufeld EJ, Yaish HM, Rothman JA, Sharma M et al..  2021.  Pyruvate kinase deficiency in children.. Pediatr Blood Cancer. 68(9):e29148.

Fassel H, Sheth S.  2020.  Bone Marrow Failure in Children: Approach to Diagnosis and Treatment.. Indian J Pediatr. 87(2):141-149.

Al-Samkari H, van Beers EJ, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kuo KHM, Kollmar N et al..  2020.  Characterization of the severe phenotype of pyruvate kinase deficiency.. Am J Hematol.

Hoshino A, Kim HSang, Bojmar L, Gyan KEnnu, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S et al..  2020.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.. Cell. 182(4):1044-1061.e18.

Betts M, Flight PA, L Paramore C, Tian L, Milenković D, Sheth S.  2020.  Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.. Clin Ther. 42(2):322-337.e2.

Nellis ME, Levasseur J, Stribling J, E Faustino VS, Zantek ND, Sheth S, Karam O.  2019.  Bleeding Scales Applicable to Critically Ill Children: A Systematic Review.. Pediatr Crit Care Med. 20(7):603-607.

Weiss M, Jun MParisi, Sheth S.  2019.  Clinical and economic burden of regularly transfused adult patients with β-thalassemia in the United States: A retrospective cohort study using payer claims.. Am J Hematol. 94(5):E129-E132.

Sheth S, Allen CJ, Farrell DE, Tripp JH, Jafari R, Wang Y, Brittenham GM.  2019.  Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry.. Clin Imaging. 55:65-70.

van Beers EJ, van Straaten S, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA et al..  2019.  Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.. Haematologica. 104(2):e51-e53.

Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, Guo Y, Deh K, Liu Z, Margolis D et al..  2019.  Rapid automated liver quantitative susceptibility mapping.. J Magn Reson Imaging. 50(3):725-732.

Grace RF, Rose C, D Layton M, Galactéros F, Barcellini W, D Morton H, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM et al..  2019.  Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.. N Engl J Med. 381(10):933-944.

Sheth S.  2019.  Stem cell transplantation in sickle-cell disease.. Lancet Haematol. 6(11):e547-e548.

Sheth S.  2019.  Strategies for managing transfusional iron overload: conventional treatments and novel strategies.. Curr Opin Hematol. 26(3):139-144.

Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, Vasovic LV, Sheth S, Nellis ME, Shaz B et al..  2018.  Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry.. JAMA Surg. 153(9):826-833.

Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM et al..  2018.  Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.. Blood. 131(20):2183-2192.

Chien KA, Hammad HT, Gerber L, Sheth S, Sockolow R, Kucine N.  2018.  Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.. J Pediatr Gastroenterol Nutr. 66(2):286-288.

Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H et al..  2017.  Prolonged Red Cell Storage Before Transfusion Increases Extravascular Hemolysis. J Clin Invest. 127(1):375-382.

L'Acqua C, Bandyopadhyay S, Francis RO, McMahon DJ, Nellis M, Sheth S, Kernie SG, Brittenham GM, Spitalnik SL, Hod EA.  2015.  Red Blood Cell Transfusion is Associated with Increased Hemolysis and an Acute Phase Response in a Subset of Critically Ill Children. Am J Hematol. 90(10):915-20.

Sheth S.  2014.  Iron Chelation: An Update. Curr Opin Hematol. 21(3):179-85.